Literature DB >> 12821741

Familial schwannomatosis: exclusion of the NF2 locus as the germline event.

M MacCollin1, C Willett, B Heinrich, L B Jacoby, J S Acierno, A Perry, D N Louis.   

Abstract

BACKGROUND: Schwannomatosis is a recently recognized disorder, defined as multiple pathologically proven schwannomas without vestibular tumors diagnostic of neurofibromatosis 2 (NF2). Some investigators have questioned whether schwannomatosis is merely an attenuated form of NF2.
METHODS: The authors identified eight families in which a proband met their diagnostic criteria for schwannomatosis. Archived and prospectively acquired tumor specimens were studied by mutational analysis at the NF2 locus, loss of heterozygosity analysis along chromosome 22, and fluorescent in situ hybridization analysis of NF2 and the more centromeric probe BCR. Linkage analysis could be performed in six of eight families.
RESULTS: Clinical characterization of these kindreds showed that no affected family member harbored a vestibular tumor. Molecular analysis of 28 tumor specimens from 17 affected individuals in these kindreds revealed a pattern of somatic NF2 inactivation incompatible with our current understanding of NF2 as an inherited tumor suppressor gene syndrome. Linkage analysis excluded the NF2 locus in two kindreds, and showed a maximum lod score of 6.60 near the more centromeric marker D22S1174.
CONCLUSIONS: Schwannomatosis shows clinical and molecular differences from NF2 and should be considered a third major form of neurofibromatosis. Further work is needed to identify the inherited genetic element responsible for familial schwannomatosis.

Entities:  

Mesh:

Year:  2003        PMID: 12821741     DOI: 10.1212/01.wnl.0000070184.08740.e0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Ophthalmological manifestations in segmental neurofibromatosis type 1.

Authors:  M Ruggieri; P Pavone; A Polizzi; M Di Pietro; A Scuderi; A Gabriele; A Spalice; P Iannetti
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

3.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

4.  Multiple schwannomas: report of two cases.

Authors:  V K Javalkar; T Pigott; P Pal; G Findlay
Journal:  Eur Spine J       Date:  2007-01-10       Impact factor: 3.134

5.  Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.

Authors:  Miriam J Smith; Andrew J Wallace; Naomi L Bowers; Cecilie F Rustad; C Geoff Woods; Guy D Leschziner; Rosalie E Ferner; D Gareth R Evans
Journal:  Neurogenetics       Date:  2012-03-22       Impact factor: 2.660

6.  Comparative genomic hybridization and mutation analyses of sporadic schwannomas.

Authors:  Takayuki Ikeda; Sho Hashimoto; Shinichi Fukushige; Hiroaki Ohmori; Akira Horii
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

7.  High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.

Authors:  Teresita Díaz de Ståhl; Caisa M Hansson; Cecilia de Bustos; Kiran K Mantripragada; Arkadiusz Piotrowski; Magdalena Benetkiewicz; Caroline Jarbo; Leif Wiklund; Tiit Mathiesen; Gunnar Nyberg; V Peter Collins; D Gareth Evans; Koichi Ichimura; Jan P Dumanski
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

8.  Expression of HIF-1, galectin-3, cox-2 and Wilms tumor-1 protein in multiple schwannomas of the conus medullaris.

Authors:  Amr M Sarwat; Suhail Al-Salam
Journal:  J Neurooncol       Date:  2008-11-09       Impact factor: 4.130

9.  Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Authors:  Arkadiusz Piotrowski; Jing Xie; Ying F Liu; Andrzej B Poplawski; Alicia R Gomes; Piotr Madanecki; Chuanhua Fu; Michael R Crowley; David K Crossman; Linlea Armstrong; Dusica Babovic-Vuksanovic; Amanda Bergner; Jaishri O Blakeley; Andrea L Blumenthal; Molly S Daniels; Howard Feit; Kathy Gardner; Stephanie Hurst; Christine Kobelka; Chung Lee; Rebecca Nagy; Katherine A Rauen; John M Slopis; Pim Suwannarat; Judith A Westman; Andrea Zanko; Bruce R Korf; Ludwine M Messiaen
Journal:  Nat Genet       Date:  2013-12-22       Impact factor: 38.330

10.  Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas.

Authors:  Sushama Patil; Arie Perry; Mia Maccollin; Shumin Dong; Rebecca A Betensky; Tu-Hsueh Yeh; David H Gutmann; Anat O Stemmer-Rachamimov
Journal:  Brain Pathol       Date:  2008-04-15       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.